· Executive Brief
Stomach Cancer Awareness Month 2026
A practical executive framework for access, ownership, handoffs, measurement, and improvement.
Leadership signal
Stomach Cancer Awareness Month can serve as an executive operating checkpoint.
Awareness can generate questions and requests for help. Executive teams can prepare by clarifying the first point of contact, the qualified team that accepts the request, the handoff standard, and the method used to verify completion without assuming that one route fits every person.
Start by distinguishing what is known from what the organization still needs to learn. A campaign plan, communication volume, or meeting count does not establish that a route is usable. Leaders need direct listening, clear ownership, locally defined measures, and a method for keeping exceptions visible.
Executive opening
Stomach cancer is a detection problem before it is a treatment problem
Stomach cancer is often discovered late in the United States, and no routine screening strategy exists for the general population.[5] That absence shifts early detection away from a national program and onto the design choices of each health system. Where no team owns the route from elevated risk to evaluation, the first diagnosis can arrive during an unplanned admission. Stomach Cancer Awareness Month gives executives a reason to ask who owns that route today, and how they would know if it failed.
The national picture is improving, but unevenly. Between 1999 and 2020 there were 276,023 gastric cancer deaths among U.S. adults aged 25 and older, and mortality declined overall.[15] Declines were slower among Hispanic adults and in rural areas, and mortality rose among adults aged 35 to 44.[15] National averages therefore hide the populations where the pathway works least well.
Risk in this disease is concentrated and largely identifiable. Hispanic, Asian or Pacific Islander, and non-Hispanic Black individuals had nearly twice the incidence of regional and distant-stage diagnoses seen in non-Hispanic White individuals.[1] Helicobacter pylori, a major cause of noncardia gastric cancer, is commonly acquired early in life in regions with a high incidence of disease.[10] Many people at elevated risk are therefore immigrants whose risk began long before they entered a U.S. clinic.
This brief adds evidence to the operating framework already on this page. It summarizes what current studies show about burden, prevention, diagnostic routes, equity and communication. It then translates those findings into questions that leaders can own. It does not offer individual medical advice, and decisions about testing, treatment and surveillance remain with qualified clinicians working within local policy.
Current evidence
The evidence shows a detectable risk that is unevenly shared
Stage at diagnosis is the clearest operating signal. In national registry data from 2009 to 2019, the rate ratio for regional-stage diagnosis was 1.87 for Hispanic individuals compared with non-Hispanic White individuals.[1] It was 2.17 for Asian or Pacific Islander individuals, and distant-stage rate ratios were 1.92 and 1.58 for the same two groups.[1] The excess was limited to noncardia and overlapping or unspecified tumors, and the authors called for strategies to improve early detection.[1]
Risk follows migration history rather than ending at the border. In a population-based cohort in Hawaii and California, first-generation Japanese descendants had the highest risk compared with non-Hispanic White participants (hazard ratio 4.62).[6] Risk remained elevated in the third generation (hazard ratio 2.57).[6] In California and New York, age-adjusted incidence ranged from about 12 to 26 per 100,000 in Korean populations.[4] The comparable range in non-Hispanic White populations was about 3.6 to 4.7 per 100,000.[4]
Latino populations carry a similar excess. A meta-analysis of 13 population-based registry studies in the United States and Canada found an overall incidence risk ratio of 2.68 for Latinos compared with non-Hispanic Whites.[9] Social position explains part of the national gap but not all of it. A state-level analysis covering 1990 to 2021 found that income and education together mediated 22% to 31% of racial and ethnic disparities.[8] States with higher Asian populations showed roughly fourfold greater incidence than states with larger Hispanic populations.[8]
Hospital care has improved, yet disparities persist inside the walls. Across 137,951 gastric cancer patients in a national hospital database from 2003 to 2022, admissions declined by 82% and in-hospital mortality by 60%.[2] Black patients still had higher odds of in-hospital mortality (odds ratio 1.17) and underwent surgery less often (odds ratio 0.85).[2] In the West, Asian patients also had higher odds of in-hospital mortality (odds ratio 1.35).[2]
These studies are observational and draw on different populations, years and definitions. Together they describe where risk sits and where outcomes diverge. They do not establish which intervention will close a given gap, which is why each organization needs its own stratified measures before it commits resources. For a board, the practical reading is simple. Gastric cancer risk is concentrated in groups the organization can name, and late-stage diagnosis is the outcome most worth tracking. Those two facts should anchor any local scorecard.
Figure 1
Where the gastric cancer prevention and care pathway leaks
Percent of each study population with the finding shown, as reported in each study. Values are copied from the cited studies [3], [5], [10], [11], [12]; none is estimated.
Data note. These values come from different studies, populations, years and denominators, so this is an indirect comparison; the bars show where the pathway leaks, not how one step compares with another.
Limitation. The infection and awareness figures come from Korean-born community participants, the metaplasia figure from a largely Hispanic safety-net population, the enrollment figure from one pilot, and the palliative figure from national registry data.
Figure data (5 rows)
| Measure | Value | Population, setting and year as reported | Source |
|---|---|---|---|
| Lifetime Helicobacter pylori infection among Korean-born adults | 50% | 282 Korean-born adults with valid results at 14 community events in Connecticut, New Jersey and New York, June to October 2025 | [10] |
| Recognized that Helicobacter pylori can cause gastric cancer | 58.9% | Korean-born adults surveyed and tested at the same community events, 2025 | [11] |
| Intestinal metaplasia among patients with active infection | 28.9% | 273 patients in a Houston, Texas safety-net health system, 92.3% Hispanic | [12] |
| Enrolled when offered upper endoscopy with screening colonoscopy | 26.6% | Individuals contacted for a single-center U.S. pilot, adults aged 45 to 80 | [5] |
| Received palliative-intent treatment for stage IV disease | 19.3% | 73,990 U.S. adults with stage IV gastric cancer in a national cancer registry, 2004 to 2021 | [3] |
Continuum of care
The route from infection to diagnosis has several fragile handoffs
Prevention in gastric cancer begins years before symptoms appear. The handoffs that matter run from testing to treatment, from treatment to confirmation, and from precancerous findings to surveillance. Each one crosses a boundary between community settings, primary care, gastroenterology and pathology. Each boundary is a place where responsibility can quietly lapse. In many organizations, no single service owns the patient between a positive test and the next appointment. The test may be ordered in primary care, treatment prescribed by another clinician, and confirmation never scheduled.
Treatment does not always close the episode. In community testing of Korean-born adults in three northeastern states, 35.1% reported a prior clinician diagnosis of infection, and 87.9% of those reported treatment.[10] Yet 8.0% of previously treated participants had a current infection at testing.[10] A pathway that records treatment without confirming the result leaves that group outside anyone’s view.
Precancerous change is common once active infection is present. In a Houston safety-net population that was mostly Hispanic and first-generation immigrant, 28.9% of patients with active infection had gastric intestinal metaplasia, a precursor of gastric cancer.[12] Prevalence did not vary between sociodemographic groups.[12] For a health system, a positive test can therefore open a longer surveillance relationship rather than end with a single prescription. Surveillance intervals remain clinical decisions, but the tracking system that keeps patients visible is an operating decision.
The route to diagnosis also shapes what happens next. In a single-institution surgical cohort from 2016 to 2023, patients diagnosed as inpatients were less likely to be Asian (62% versus 82%) or to report family history (17% versus 45%).[13] Their median length of stay was 8 days, compared with 5 days for patients diagnosed as outpatients.[13] The authors described them as a distinct cohort not captured by the risk indicators that prompt opportunistic endoscopy.[13] Reviewing each inpatient diagnosis as a possible missed outpatient opportunity gives leaders a concrete learning signal.
Continuity matters after diagnosis as well. Among Medicare beneficiaries aged 68 and older, patients with pre-existing psychiatric disorders were more likely to be diagnosed at an early stage.[7] Yet they had higher overall mortality (adjusted hazard ratio 1.17).[7] Early detection alone does not guarantee a reliable journey through treatment, recovery and follow-up. Handoffs between oncology, surgery, behavioral health and primary care deserve the same ownership discipline as the earliest steps.
Figure 3
Why the pathway breaks
People
- Limited endoscopy and anesthesia staffing for added procedures
- Too few interpreters and navigators for high-risk communities
- Limited palliative care coverage outside large teaching hospitals
Process
- Positive Helicobacter pylori tests treated without confirming eradication
- No surveillance owner after precursor lesions are found
- Opportunistic upper endoscopy not offered at existing colonoscopy visits
Technology
- Records do not capture birthplace, ancestry subgroup or family history
- No registry to track patients with intestinal metaplasia
- Pathology results not routed to an accountable follow-up owner
Environment
- Early-life infection acquired before migration
- Low income and education limiting timely care
- Geographic distance from endoscopy and specialty surgery
Policy
- No routine U.S. screening strategy for the general population
- Eligibility rules based on birthplace alone
- Uneven insurance coverage for palliative and supportive care
Measurement
- Asian and Hispanic populations reported as single categories
- Stage at diagnosis and diagnostic route not tracked
- Awareness and perceived risk not measured in outreach programs
Unranked qualitative cause-and-effect diagram for the outcome in the box: High-risk patients are diagnosed with gastric cancer at a regional or distant stage, often during an unplanned admission Causes are assembled from the cited literature [1], [2], [3], [4], [5], [8], [10], [11], [12], [13], [14]; categories are not weighted and their order carries no meaning.
Data note. Qualitative; no frequencies are implied.
Limitation. Causes drawn from published studies may not all apply locally; validate them with frontline teams.
Figure data (6 rows)
| Category | Causes drawn from the cited literature |
|---|---|
| People | Limited endoscopy and anesthesia staffing for added procedures; Too few interpreters and navigators for high-risk communities; Limited palliative care coverage outside large teaching hospitals |
| Process | Positive Helicobacter pylori tests treated without confirming eradication; No surveillance owner after precursor lesions are found; Opportunistic upper endoscopy not offered at existing colonoscopy visits |
| Technology | Records do not capture birthplace, ancestry subgroup or family history; No registry to track patients with intestinal metaplasia; Pathology results not routed to an accountable follow-up owner |
| Environment | Early-life infection acquired before migration; Low income and education limiting timely care; Geographic distance from endoscopy and specialty surgery |
| Policy | No routine U.S. screening strategy for the general population; Eligibility rules based on birthplace alone; Uneven insurance coverage for palliative and supportive care |
| Measurement | Asian and Hispanic populations reported as single categories; Stage at diagnosis and diagnostic route not tracked; Awareness and perceived risk not measured in outreach programs |
Access
Access improves when existing visits become prevention opportunities
Many high-risk adults already touch the health system for other reasons. A single-center pilot offered upper endoscopy at the time of a scheduled screening colonoscopy to adults aged 45 to 80.[5] Of those contacted, 51.6% expressed interest and 26.6% enrolled.[5] The median added procedure time was 17 minutes, and no complications occurred.[5] The approach relies on an appointment that has already been booked, prepared for and staffed.
Patient response in that pilot was strongly favorable. All 40 survey respondents rated the combined procedure satisfactory, and 97.5% preferred it.[5] Biopsies identified Helicobacter pylori infection in 32% of participants, atrophic gastritis in 14% and intestinal metaplasia in 12%.[5] These are results from one center and 50 participants, so they show feasibility rather than population benefit. A larger program would still need clear eligibility criteria, consent processes and a plan for every abnormal biopsy result.
Community settings can reach people before they become patients. Fourteen outreach events in Connecticut, New Jersey and New York produced valid breath test results for 282 Korean-born adults.[10] Lifetime infection prevalence was 50.0% and remained similar across categories of duration of U.S. residence.[10] Among participants who reported endoscopy data, 78.4% had undergone upper endoscopy, most commonly for routine screening.[10] The authors concluded that public health efforts can identify people at risk and link them to eradication and surveillance.[10]
Access gaps also appear later in the pathway. Among 73,990 adults with stage IV gastric cancer in a national cancer registry, only 19.3% received palliative-intent treatment.[3] In national hospital data, Black patients were less often discharged home (odds ratio 0.86).[2] They also experienced more perioperative complications (odds ratio 1.11).[2] Access is therefore a whole-pathway measure, not only a front-door measure.
Executives can use these findings to test local capacity. The practical questions are whether endoscopy slots, pathology turnaround and referral rules can absorb risk-based demand. Leaders should also ask whether that capacity is reachable from the clinics and community sites that serve high-risk neighborhoods. They should ask how a person identified at a community event is scheduled, by whom and how quickly. Where the answer depends on patients finding their own way, the route is not yet an access pathway. Transportation, preparation instructions in the patient’s language and an escort after sedation are practical barriers that deserve explicit review.
Executive guidance · System route
Build one visible operating route for Stomach Cancer Awareness Month.
Use this route as a discussion framework. Replace each stage with the organization’s approved process, qualified roles, current service capacity, and applicable requirements. Do not infer a clinical protocol from the observance title.
The route at a glance
- Listen
- Clarify entry
- Navigate across services
- Protect transitions
- Verify and learn
Reliability rule: Every stage needs a named owner, an observable status, an approved escalation path, and a defined signal that shows whether responsibility moved or remained unresolved.
Listen
Gather questions and friction points from people using the route, frontline teams, and community-facing staff. Separate observed barriers from assumptions.
Clarify entry
Publish a plain-language first step and identify who receives requests through each approved channel.
Navigate across services
Make the receiving service, required information, current status, and next accountable owner visible whenever the route crosses an organizational boundary.
Protect transitions
Use acknowledgment and status visibility when responsibility moves between services, locations, or organizations.
Verify and learn
Review unresolved work, repeat contacts, and avoidable handoffs. Use the findings to improve the route rather than blame individuals.
Figure 2
The system route as one flow
The five stages of the system route described in this brief, drawn as one flow with a learning loop back to the start. The stages are the page’s original executive guidance, not a clinical protocol.
Data note. Shows sequence and handoffs only; it carries no counts or rates.
Limitation. Local processes may add, merge or reorder stages under organizational policy.
Figure data (5 rows)
| Stage | What the stage requires |
|---|---|
| Listen | Gather questions and friction points from people using the route, frontline teams, and community-facing staff. Separate observed barriers from assumptions. |
| Clarify entry | Publish a plain-language first step and identify who receives requests through each approved channel. |
| Navigate across services | Make the receiving service, required information, current status, and next accountable owner visible whenever the route crosses an organizational boundary. |
| Protect transitions | Use acknowledgment and status visibility when responsibility moves between services, locations, or organizations. |
| Verify and learn | Review unresolved work, repeat contacts, and avoidable handoffs. Use the findings to improve the route rather than blame individuals. |
Equity and trust
Equity depends on disaggregated data and language-ready care
Aggregate categories can hide the people at greatest risk. When Asian populations in California and New York were disaggregated into Chinese, Japanese, Korean and Vietnamese subgroups, Korean populations consistently showed the highest incidence.[4] Incidence declined significantly over time in California but not in New York.[4] A health system that reports a single Asian category cannot see that variation in its own data. Disaggregation is a registration and data governance choice, and it should be treated as one.
Hispanic subgroups also differ. Among patients with stage IV disease, odds of palliative-intent treatment were lower for Mexican patients (adjusted odds ratio 0.74) than for non-Hispanic White patients.[3] Odds were also lower for Cuban (0.57) and South or Central American (0.73) patients.[3] The authors suggested that these inequities likely reflect intersecting socioeconomic, linguistic and structural barriers, and they called for improved language access.[3]
Latino risk is not confined to recent arrivals. The pooled incidence risk ratio for Latinos rose to 3.55 when analysis was restricted to non-cardia adenocarcinoma.[9] The authors concluded that this elevated risk persists for at least one generation.[9] Among Japanese descendants, risk declined across generations but remained significantly higher than among non-Hispanic White participants.[6] Outreach rules based only on birthplace would miss many people who share the same risk. Family history and ancestry, recorded respectfully, can widen the lens.
End-of-life care shows a similar pattern. Among 13,435 weighted hospitalizations of gastric cancer patients that ended in death, 57.6% included palliative care.[14] Black patients had 32% lower odds of receiving palliative care than White patients.[14] Higher use was associated with greater income, large hospitals, urban teaching hospitals and private or other insurance.[14] Palliative care was also associated with less intensive care without prolonging length of stay.[14]
Because income and education explained part of the racial and ethnic gap in burden, equity work cannot rely on cultural messaging alone.[8] It also needs interpreter capacity, financial counseling, transportation support and navigation for patients without a usual source of care. Leaders should review stratified results with community partners who can explain what the numbers miss. Equity review should cover the whole route, from who is offered testing to who receives palliative support near the end of life.
Human infrastructure
Human infrastructure carries the prevention pathway
Every step in this pathway depends on people with specific skills. Endoscopists, pathologists, navigators, interpreters, community health workers, behavioral health clinicians and palliative care teams each hold one link. When one group is understaffed, the delay usually surfaces downstream as a later stage or an unplanned admission. Workforce planning for this observance should begin with an inventory of who performs each step and how much capacity they hold.
Endoscopy capacity is the most visible constraint. In the opportunistic endoscopy pilot, the combined procedure added a median of 17 minutes, with a range of 9 to 26 minutes.[5] Across a full colonoscopy schedule, that time becomes a staffing decision for nursing, anesthesia and recovery teams. Leaders should model the added time before expanding any risk-based program. Scheduling templates, preparation instructions and consent workflows would also need updates.
Pathology and tracking form a second constraint. The Houston safety-net study used systematic gastric mapping biopsies, and 8.1% of patients with active infection had extensive intestinal metaplasia.[12] Surveillance built on such findings requires pathologists, registry staff and scheduling capacity that last for years, not weeks. Without a named owner, these patients can easily drift out of contact. Prevalence did not vary between sociodemographic groups, so surveillance demand will not be confined to one clinic.[12]
Patients with complex needs require coordinated teams. Among 15,882 older adults with gastric cancer, 12% had a pre-existing psychiatric disorder.[7] Those with serious psychiatric disorders had higher cancer-specific mortality (adjusted subdistribution hazard ratio 1.25).[7] Patients with psychiatric disorders also differed in demographics, comorbidities and cancer characteristics.[7] That complexity makes individualized coordination more important. Linking oncology navigation with behavioral health support is therefore part of the core workforce plan.
Palliative care capacity is unevenly distributed. In end-of-life gastric cancer hospitalizations, higher palliative care use was associated with large hospitals and urban teaching hospitals.[14] Palliative care was also linked to a $36,240 reduction in hospital charges.[14] Community hospitals may need shared or virtual palliative services to offer comparable support to the patients they serve. Community health workers and interpreters drawn from high-risk communities can extend the reach of every clinical role. Their work should be funded, supervised and measured like any other clinical service, not treated as a volunteer add-on.
Executive guidance · Operating dashboard
Use a small dashboard to expose friction and ownership.
Do not publish a number until the organization defines its numerator, denominator where relevant, owner, source system, exclusions, review cadence, and limits. The candidates below are management prompts, not benchmarks or reported results.
Four operating signals
Each signal pairs an executive question with one candidate local measure, set out below.
Executive guidance · Signal
Entry-point clarity
Can people and staff identify the approved first step without searching across conflicting instructions?
- Candidate local measure
- Locally defined contact, routing, and repeat-contact signals by channel and service.
Executive guidance · Signal
Ownership reliability
Does a specific team accept each request and make its status visible?
- Candidate local measure
- Requests without an owner, aged work, transfers, and escalations using locally approved definitions.
Executive guidance · Signal
Navigation continuity
Where does ownership become unclear as people move among information, evaluation, services, and follow-through?
- Candidate local measure
- Locally defined unaccepted handoffs, repeated contacts, missing information, unresolved routes, and navigation feedback.
Executive guidance · Signal
Improvement closure
Does the organization correct recurring friction and report what changed?
- Candidate local measure
- Selected barriers, assigned actions, completion status, and post-change review.
Figure 4
The operating system behind the dashboard
The four operating signals from this brief’s dashboard, each tied to the candidate owner named in the executive scorecard, around one accountable route. Drawn from the page’s original executive guidance.
Data note. Structural diagram; no measured values.
Limitation. Owners are candidates to be confirmed locally.
Figure data (4 rows)
| Operating signal | Candidate owner |
|---|---|
| Entry-point clarity | Executive sponsor and operational lead |
| Ownership reliability | Operational owner and participating teams |
| Navigation continuity | Sending and receiving owners |
| Improvement closure | Improvement owner and executive sponsor |
Executive guidance · Handoff workflow
Close the loop across teams, settings, and partners.
A handoff is reliable only when the sending party knows who is expected to receive the work, the receiving party acknowledges responsibility, and any unresolved exception remains visible. Local policy and qualified judgment control the actual process.
How responsibility moves
Lane A
From message to accepted ownership
- Confirm the approved message and intended audience.
- Publish the actual entry point and receiving role.
- Acknowledge receipt using the locally approved method.
- Escalate when ownership or response remains unclear.
Lane B
From accepted ownership to verified follow-through
- Record the next accountable owner and visible status.
- Name the receiving service and confirm acceptance without promising a clinical determination or outcome.
- Keep unresolved work visible across boundaries.
- Confirm closure or document the continuing exception.
Executive guidance · Executive scorecard
Give leaders one view of route reliability and improvement.
The scorecard keeps review focused on decisions. Leaders should set definitions locally, examine variation without overclaiming cause, and pair quantitative signals with the experience of people who use and operate the route.
Who reviews what
- Executive sponsor and operational lead
- Operational owner and participating teams
- Sending and receiving owners
- Improvement owner and executive sponsor
Candidate owners named in the scorecard, confirmed locally.
| Operating signal | Executive question | Candidate owner | Suggested review point |
|---|---|---|---|
| Entry-point clarity | Can people and staff identify the approved first step without searching across conflicting instructions? | Executive sponsor and operational lead | At campaign launch and close |
| Ownership reliability | Does a specific team accept each request and make its status visible? | Operational owner and participating teams | At a locally defined cadence |
| Navigation continuity | Where does ownership become unclear as people move among information, evaluation, services, and follow-through? | Sending and receiving owners | At a locally defined cadence |
| Improvement closure | Does the organization correct recurring friction and report what changed? | Improvement owner and executive sponsor | Until action is verified |
Figure 5
Control points for a reliable gastric cancer risk pathway
| Control point | Risk if missing | Owner | Evidence of control |
|---|---|---|---|
| Disaggregated race, ethnicity, birthplace and family history captured at registration | High-risk subgroups remain invisible in aggregate reports | Chief information officer and registration leader | Share of active patients with complete subgroup and family history fields |
| Defined owner for every positive Helicobacter pylori result | Treatment is prescribed but eradication is never confirmed | Primary care medical director | Share of positive results with documented treatment and confirmation testing |
| Surveillance registry for patients with precursor lesions | Patients with intestinal metaplasia drift out of contact | Gastroenterology service line leader | Registry completeness and share of patients seen within the locally approved interval |
| Endoscopy and pathology capacity plan for risk-based demand | Added procedures lengthen waits for all patients | Chief operating officer | Third-next-available endoscopy appointment and pathology turnaround by site |
| Review of every gastric cancer diagnosed during an unplanned admission | Missed outpatient opportunities are never examined | Chief medical officer and cancer committee | Case review completion rate and actions recorded |
| Interpreter and navigation coverage for high-risk communities | Language and logistics barriers delay evaluation and palliative care | Chief patient experience officer | Interpreter fill rate and navigation contact rate by language |
| Stage-at-diagnosis dashboard stratified by subgroup | Leaders cannot tell whether early detection is improving | Board quality committee | Quarterly report reviewed with documented decisions |
Control points derived from the cited evidence [1], [3], [4], [5], [10], [12], [13], [14] and this brief’s executive guidance.
Data note. Each row is a control to verify, not a measured result.
Limitation. Owners and evidence of control must follow local policy and applicable requirements.
Public communication
Communication must close the awareness gap without overpromising
High engagement does not guarantee understanding. Among Korean-born adults tested at community events, 78.4% reported prior upper endoscopy.[11] Yet only 58.9% recognized that Helicobacter pylori can cause gastric cancer, and 48.8% recognized the elevated gastric cancer risk among Koreans.[11] The authors described this combination as an important educational gap.[11] Clinicians and outreach staff can easily mistake high procedure use for high understanding.
Awareness and action appear to travel together. Prior endoscopy was more common among participants who were aware of the link between infection and gastric cancer (85.2% versus 68.8%).[11] This is a cross-sectional association, so it does not show that education alone changes behavior. It does suggest that culturally responsive education can build on trust that already exists. Current infection was less frequent among aware participants, although that difference was not statistically significant.[11]
Perceived severity is a second gap. In the colonoscopy-linked pilot, 72% of respondents viewed screening as beneficial, but only 23.3% perceived gastric cancer as severe.[5] None considered themselves highly susceptible, and nearly half lacked awareness of gastric cancer risk factors.[5] Messages for this month should explain risk plainly and in the languages people actually use. Messages should be tested with members of the intended audience before launch and revised when they do not land.
Communication also has to reach clinicians. Patients diagnosed during an inpatient stay were not captured by the family history, ancestry or prior infection cues that usually prompt evaluation.[13] Clinician education should describe the groups at elevated risk without implying that risk belongs to a single community. Prompts in the record and brief case reviews can reinforce that message more reliably than a single lecture.
Public messaging should also be honest about what the system can deliver. A campaign that raises demand for testing or endoscopy without matching capacity can erode the trust that communities have extended. The strongest message pairs accurate risk information with a clear, staffed and answerable next step. Every public statement should point to a specific entry point, and someone should confirm that the entry point responds. If capacity is limited, outreach can be staged by risk group rather than broadcast to everyone at once. That approach protects credibility and lets teams learn before scaling.
Executive guidance · 90-day plan
Turn the observance into one sustained operating change.
The time boxes below are a management framework, not a clinical timeline. Adjust them to risk, scope, governance, resources, stakeholder participation, and applicable review requirements.
Ninety days, three moves
- Days 1–30See the current route
- Days 31–60Build the reliable path
- Days 61–90Make the change visible
Days 1–30 · Listen and map
See the current route
- Name an executive sponsor and an operational owner.
- Listen to people using the route and representative frontline teams.
- Map how Stomach Cancer Awareness Month communications connect to real entry points, owners, transitions, and escalation.
- Select one recurring barrier that the organization can responsibly address.
Days 31–60 · Design and test
Build the reliable path
- Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal.
- Validate the design with every sending and receiving team involved.
- Test one cross-service navigation handoff and correct the point where status or ownership becomes unclear.
- Test the route in more than one representative setting or operating period where practical.
Days 61–90 · Implement and verify
Make the change visible
- Launch the redesigned route with a small set of locally defined measures.
- Review unresolved work and recurring friction using a learning approach.
- Correct implementation barriers and record who owns each remaining dependency.
- Report what changed, what evidence was reviewed, and what still requires live oversight.
Figure 6
The 90-day plan on one timeline
The 90-day plan from this brief drawn as a timeline: each action sits in the 30-day window the plan assigns it. The full wording of each action is in the figure data and in the plan above.
Data note. Time boxes are a management framework, not a clinical timeline.
Limitation. Durations are uniform 30-day windows; real tasks may span windows.
Figure data (12 rows)
| Window | Action |
|---|---|
| Days 1–30 · Listen and map | Name an executive sponsor and an operational owner. |
| Days 1–30 · Listen and map | Listen to people using the route and representative frontline teams. |
| Days 1–30 · Listen and map | Map how Stomach Cancer Awareness Month communications connect to real entry points, owners, transitions, and escalation. |
| Days 1–30 · Listen and map | Select one recurring barrier that the organization can responsibly address. |
| Days 31–60 · Design and test | Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal. |
| Days 31–60 · Design and test | Validate the design with every sending and receiving team involved. |
| Days 31–60 · Design and test | Test one cross-service navigation handoff and correct the point where status or ownership becomes unclear. |
| Days 31–60 · Design and test | Test the route in more than one representative setting or operating period where practical. |
| Days 61–90 · Implement and verify | Launch the redesigned route with a small set of locally defined measures. |
| Days 61–90 · Implement and verify | Review unresolved work and recurring friction using a learning approach. |
| Days 61–90 · Implement and verify | Correct implementation barriers and record who owns each remaining dependency. |
| Days 61–90 · Implement and verify | Report what changed, what evidence was reviewed, and what still requires live oversight. |
Executive guidance · Leadership close
Make Stomach Cancer Awareness Month a starting point, not an endpoint.
Recognition matters. It becomes durable when leaders also listen, clarify the route, support the people operating it, close an identified gap, and report the result without claiming more than the evidence supports.
Leadership commitment
Make ownership visible, test the route, and report what improved.
Executive action kit · Month observance
Turn Stomach Cancer Awareness Month into accountable action.
A practical executive framework for access, ownership, handoffs, measurement, and improvement.
Leadership focus
Use this observance to examine navigation, longitudinal ownership, and specialty-care coordination. Select one verified barrier, assign an accountable owner, and carry the improvement beyond the campaign window.
Workforce lens
Ask whether staffing, role clarity, training, tools, workload, and escalation support the people operating the information, diagnostic navigation, support, and follow-through pathway.
Patient and community lens
Make the approved first step clear. Test whether a person can move from information to an acknowledged next action without navigating conflicting instructions.
Equity and access lens
Review whether language, transportation, cost, digital access, disability, geography, or trust changes a person’s ability to complete the locally approved route.
Five-minute briefing
Inspect the operating sequence
Listen with people using the pathway, caregivers, navigation teams, clinical services, and community partners. Find one a confusing entry point, unowned transition, or unresolved navigation need, then test the locally approved route from entry through acknowledged follow-through.
- Listen
- Clarify entry
- Navigate across services
- Protect transitions
- Verify and learn
Leadership actions for this week
- Name an executive sponsor and frontline operating owner.
- Ask people using and operating the pathway where ownership becomes unclear.
- Test one representative route from first question to acknowledged next step.
- Select one barrier that can be corrected without overstating the evidence.
- Set a review date and define how completion will be verified.
Candidate measures
Define every numerator, denominator where relevant, owner, data source, exclusions, cadence, and limitation locally. These are management prompts, not external benchmarks.
- Locally defined contact, routing, and repeat-contact signals by channel and service.
- Requests without an owner, aged work, transfers, and escalations using locally approved definitions.
- Locally defined unaccepted handoffs, repeated contacts, missing information, unresolved routes, and navigation feedback.
Department readiness checklist
- The public and staff entry points match the actual approved process.
- A specific role accepts each request, referral, or escalation.
- Handoffs include acknowledgment and a visible unresolved state.
- Language, disability, digital, transportation, and trust barriers receive explicit review.
- Communications do not introduce unsupported themes, statistics, or clinical advice.
- A named leader will review what changed after the observance.
Intended audiences
- Executive and Operational Leaders
- Patient Experience and Access Leaders
Staff communication template
During Stomach Cancer Awareness Month, our organization will connect awareness with a practical review of the information, diagnostic navigation, support, and follow-through pathway. Use approved information, identify the correct entry point, confirm ownership when work moves, protect privacy, and escalate unresolved barriers through local channels.
Community communication template
Stomach Cancer Awareness Month is an opportunity to share trustworthy information and make the next step easier to find. Use our approved channels for information and support. If a request changes hands, our goal is to keep ownership and follow-through visible.
Measurement worksheet
- Signal
- What observable condition will show whether the route works?
- Definition
- What is included, excluded, and counted?
- Owner
- Who reviews the signal and acts on exceptions?
- Cadence
- When will leaders review it?
- Equity check
- Which differences require protected, locally appropriate review?
- Closure
- What evidence will confirm the improvement was completed?
- Editorial review
- Completed
- Source records
- 2 listed under Authoritative resources
- Review standard
- Sourced facts remain separated from original executive guidance
- Clinical boundary
- No new statistical or clinical claim was added by this action kit
Sources and content boundary
Authoritative resources
Use note: All operating models, measures, scorecard questions, and action steps are original executive guidance. This article supports leadership planning and education. It does not replace clinical judgment, emergency procedures, legal advice, professional standards, organizational policy, or applicable federal, state, and local requirements.
Peer-reviewed references
References
Fifteen peer-reviewed sources, newest first. Each was individually verified through authenticated academic research databases. Bracketed numbers in the text link here; the original executive guidance on this page carries no citations because it is guidance, not a sourced claim. Sources last checked in those databases on .
- 1.Urujeni C, Epplein M, Li CI, Pete D. Racial and Ethnic Differences in Gastric Cancer by Stage of Diagnosis in the United States (2009–2019). Cancer Epidemiology, Biomarkers & Prevention. 2026;35(6):995-1000. https://doi.org/10.1158/1055-9965.epi-25-1356
- 2.Shiratori Y, Sharma N, Kodilinye SM, Parraga CB, Khan F, Salem AE, et al. Hospital-based gastric cancer outcomes in the United States (2003–2022): racial and regional disparities. Gastric Cancer. 2026;29(5):940-948. https://doi.org/10.1007/s10120-026-01765-4
- 3.Chou C, Y Garcia C, Garg SK, Leung W, Kwon M, Cano C, et al. Disparities in the Receipt of Palliative-intent Treatment Across Disaggregated Hispanic Subgroups With Stage IV Gastric Cancer in the United States. American Journal of Clinical Oncology. 2026;49(6):281-286. https://doi.org/10.1097/coc.0000000000001297
- 4.Hyun CS, Wang R, Hong SH, Zhang X, Shin JI. Migration‐Associated Variation in Gastric Cancer Risk in the United States: Implications for Risk Stratification. International Journal of Cancer. 2026;159(8):1891-1903. https://doi.org/10.1002/ijc.70552
- 5.In H, De la Torre-Cisneros K, Rana B, Myrthil-Harder P, Adams A, Dalal I, et al. Opportunistic Upper Endoscopy at the Time of Screening Colonoscopy: Feasibility, Acceptability, and Patient Perspectives. Gastro Hep Advances. 2026;5(11):101082. https://doi.org/10.1016/j.gastha.2026.101082
- 6.In H, De la Torre-Cisneros K, Adams A, Chen C, Rana B, Wilkens L, et al. Generational immigration status and gastric cancer incidence among Japanese descendants: an analysis of the Multiethnic Cohort (MEC) Study. Cancer Causes & Control. 2026;37(10):168. https://doi.org/10.1007/s10552-026-02250-0
- 7.Soddano J, Wagner S, Yoon JY, Yang JY, Chen L, Huang Y, et al. The Impact of Pre‐Existing Psychiatric Disorders on Gastric Cancer Stage and Mortality in Older Adults. Cancer Medicine. 2026;15(6):e71622. https://doi.org/10.1002/cam4.71622
- 8.Kim YS, Oh SS, Hong SH, Kim M, Yon DK, Shin JI, et al. Beyond Incidence and Mortality: Socioeconomic Mediation of Gastric Cancer Disparities in the United States, 1990–2021. Annals of Global Health. 2026;92(1):14. https://doi.org/10.5334/aogh.5015
- 9.Corral JE, Kim DH, Shah S, Khanolkar A. Gastric Cancer Incidence Among Latino Groups Living in the United States and Canada: A Meta-analysis of Population Based Cancer Registries. Journal of Gastrointestinal Cancer. 2026;57(1):67. https://doi.org/10.1007/s12029-026-01436-8
- 10.Hyun CS, Hong SH, Zhang X, Shin JI, Kim SS, Laine L. Community-Based Helicobacter pylori Screening to Identify Gastric Cancer Risk Among Korean-Born Adults in the United States. Public Health Reports. 2026:00333549261460001. https://doi.org/10.1177/00333549261460001
- 11.Hyun CS, Roh A, Lee YJ, Kim SS. Gaps in Gastric Cancer Risk Awareness Despite High Preventive Engagement among Korean-Born Adults in the United States. Journal of Cancer Education. 2026. https://doi.org/10.1007/s13187-026-02987-x
- 12.Thrift AP, Chandrasekhara K, Zarrin-Khameh N, Juarez L, Brown J, Avila D, et al. Prevalence of Gastric Intestinal Metaplasia Among Patients with Active Helicobacter Pylori Infection Served by a Safety-Net Healthcare System. Digestive Diseases and Sciences. 2026. https://doi.org/10.1007/s10620-026-10254-8
- 13.Hong JS, Champigneulle O, Chao SY, Saldinger PF, Hyun J, Zheng J. Inpatient Versus Outpatient Diagnosis of Gastric Adenocarcinoma: Differences in Stage, Risk Factors, and Surgical Outcomes. The American Surgeon. 2026:00031348261484508. https://doi.org/10.1177/00031348261484508
- 14.Lee J, Lee J, Tripathi R, Stein D, Rao B, Jamorabo D, et al. Sociodemographic Disparities and Impact of Palliative Care Utilization During End-of-Life Hospitalizations in Patients with Gastric Cancer. Journal of Palliative Medicine. 2025;29(4):437-442. https://doi.org/10.1177/10966218251403303
- 15.Khan M, Bin Gulzar AH, Shahid F, Mohamed BH, Lal A, Rath S, et al. Gastric Cancer Mortality in the United States. American Journal of Clinical Oncology. 2025;49(2):76-81. https://doi.org/10.1097/coc.0000000000001235
Claim-to-source matrix
What each source supports
Every sourced claim in the new sections maps to the references that support it, the section where it is used, and the limitation a reader should keep in mind. Original executive guidance carries no sources because it is guidance, not a finding.
| Claim group | Sources | Years | Used in | Limitation |
|---|---|---|---|---|
| Stage at diagnosis by race and ethnicity | [1] | 2026 | Current evidence | Registry data from 2009 to 2019; broad racial and ethnic categories; stage recorded at diagnosis only. |
| Migration-associated and generational risk in Asian American populations | [4] [6] | 2026 | Current evidence | California, New York and Hawaii populations; cohort enrolled in the 1990s; extrapolations are scenario based. |
| Elevated incidence among Latinos | [9] | 2026 | Equity and trust | Meta-analysis with significant heterogeneity; includes Canadian registries; birthplace difference not statistically significant. |
| Socioeconomic mediation of disparities | [8] | 2026 | Equity and trust | Modeled state-level estimates; ecological design cannot show individual-level effects. |
| National mortality trends | [15] | 2025 | Executive opening | Death certificate data from 1999 to 2020; coding of cause of death may vary. |
| Hospital outcomes and in-hospital disparities | [2] | 2026 | Current evidence | Administrative hospital data; in-hospital outcomes only. |
| Helicobacter pylori infection, treatment and reinfection or persistence in community testing | [10] | 2026 | Continuum of care | Convenience sample at 14 community events among Korean-born adults; prior diagnosis self-reported. |
| Precursor lesions after active infection in a safety-net population | [12] | 2026 | Continuum of care | Single safety-net system in Houston; mostly Hispanic women; cross-sectional design. |
| Inpatient versus outpatient diagnostic routes | [13] | 2026 | Continuum of care | Single-institution surgical cohort of patients who underwent surgery; small inpatient group (29 patients). |
| Opportunistic upper endoscopy at screening colonoscopy | [5] | 2026 | Access | Single-center, single-arm pilot of 50 participants; no comparison group; outcomes are feasibility and yield. |
| Palliative care and palliative-intent treatment disparities | [3] [14] | 2026, 2025 | Equity and trust | Registry and administrative data; palliative intent and palliative care identified from coded fields. |
| Psychiatric comorbidity and gastric cancer outcomes | [7] | 2026 | Human infrastructure | Medicare beneficiaries aged 68 and older; psychiatric disorders identified from claims. |
| Risk awareness and preventive engagement | [11] [5] | 2026 | Public communication | Cross-sectional surveys in community and single-center samples; associations are not causal. |
About the author
Greg Wahlstrom
MBAHCM
President and Chief Executive Officer, The Healthcare Executive
View Greg’s profile©2014 – 2026 The Healthcare Executive. All rights reserved.